This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Cancer Immunology and Immunotherapy
joint with Antibodies as Drugs
Organizer(s): Glenn Dranoff, Carl H. June and Suzanne L. Topalian
Date: January 27 - February 01, 2013
Location: Fairmont Hotel Vancouver, Vancouver, BC, Canada
Sponsored by Bayer USA Foundation and Bristol-Myers Squibb Company. Supported by an educational donation provided by Amgen.
Summary of Meeting:
The recent FDA approvals of Provenge® as the first therapeutic cancer vaccine and Ipilimumab® as the first monoclonal antibody that blocks negative immune regulation are landmark achievements that highlight substantive progress in cancer immunology. These novel treatments derive from the cumulative insights of basic and translational scientists into the mechanisms of protective tumor immunity in cancer patients. Advances in genetic, cellular and biochemical technologies have dramatically increased our understanding of the pathways through which the host responds to cancer. Tumor-host interactions in the microenvironment are increasingly recognized to play a critical role in determining disease inhibition or promotion. This Keystone Symposia meeting will bring together leading cancer immunologists to discuss their most recent insights into immune recognition, regulation, tumor escape and therapeutic manipulation. Emerging areas of cancer metabolism and material science engineering that relate to cancer immunology will be highlighted. The integration of basic and clinical aspects of tumor immunity in this meeting should stimulate interest from a wide array of investigators and students. The concurrent meeting on Antibodies as Drugs will underscore the increasing connections between these fields, and potentially accelerate the development of new cancer immunotherapies.
Scholarship Deadline: September 25 2012
Discounted Abstract Deadline: September 25 2012
Abstract Deadline: October 25 2012
Discounted Registration Deadline: November 27 2012
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Educational donation provided by AmgenBayer USA FoundationBristol-Myers Squibb Company
We gratefully acknowledge additional support for this conference from:
Cell Signaling Technology, Inc.Landes BioscienceMyriad-RBM
Ono Pharmaceutical Co. Ltd.
STEMCELL Technologies, Inc.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Immunocore Limited

Micromet, Inc.
$1 - $2,499

Cancer Immunity

Molecular Metabolism (Elsevier GmbH)
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Cancer Immunity
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found